Home Molecular Dx Infectious Disease Diagnostics

Infectious Disease Diagnostics

Random
coronavirus,3d render
Infectious Disease Diagnostics

$125M Coronavirus Accelerator Launched by Gates Foundation, Wellcome, Mastercard

coronavirus,3d render
Infectious Disease Diagnostics

Mt. Sinai Leads Medical School Consortium Fast-Tracking COVID-19 Detection Test

Infectious Disease Diagnostics

Inflammatix Nabs $6M from BARDA to Develop POC Acute Infection Diagnostic

coronavirus,3d render
Infectious Disease Diagnostics

COVID-19 Patients May Carry Virus after Symptoms Have Resolved

Myanmar: Rhesus Macaque
Infectious Disease Diagnostics

New Study Suggests COVID-19 Reinfection Unlikely

Infectious Disease Diagnostics

PlexBio, Denka to Co-Develop MDx System for Infectious Disease

coronavirus,3d render
Infectious Disease Diagnostics

Genetic Study Shows Coronavirus Evolved Naturally, Is not Lab-Constructed

Quest's test is the first from a commercial laboratory provider to be granted an EUA for testing patients for Zika virus RNA. [J.Gathany / CDC]
Infectious Disease Diagnostics

FDA Approves Quest’s Zika Test for Emergency Use

Quest Diagnostics says it will acquire the U.S. laboratory services business of Oxford Immunotec Global for an undisclosed price
Infectious Disease Diagnostics

Quest Diagnostics to Acquire Oxford Immunotec U.S. Lab Services Business

Curetis and BGI Group’s wholly-owned subsidiary MGI will partner to develop NGS in vitro diagnostic assays for microbial infection. The collaboration will combine Curetis’ Unyvero L4 Lysator (pictured) with MGI's SP100 Sample Preparation System and MGISeq NGS Sequencers. [Source: Curetis]
Infectious Disease Diagnostics

Curetis, MGI to Co-Develop NGS Assays for Microbial Infection

1234Page 1 of 4

New Products

View More
Load more
Copyright © 2020 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up